Fascination About Conolidine Proleviate for Joint Pain Treatment
Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. Contrary to opioids, which bind to µ-opioid receptors in the central anxious program, conolidine modulates alternate molecular targets. A Science Innovations review located that conolidine interacts While using the atypical chemokine receptor ACKR3/CXCR7, whi